Figure 3.
Clinical and histopathologic responses to ipilimumab therapy in a representative patient with leukemia cutis. Pretreatment (A-C) and posttreatment response (B-D) in a patient with leukemia cutis and corresponding histologic response. (C,D) Hematoxylin and eosin staining. Adapted from Davids et al68 with permission.
